Key facts
- Veracity (Personal Products)’s last known valuation is $23.6M (Jun 2025).
- It has raised $11.8M; the latest was Later Stage VC ($6.0M) in Jun 2025.
- Notable investors include Global Founders Capital, Great Oaks Venture Capital, Peterson Partners, Spacestation (UK), Tonic Ventures — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Veracity (Personal Products)
- ·The full record, as it builds
Funding rounds
No funding rounds for Veracity (Personal Products) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Veracity (Personal Products)
Manufacturer of personal care and wellness products intended to offer knowledge on hormones and other biofactors. The company provides products and test kits to check the hormonal balance in the skin and find the root cause, enabling customers to have access to personalized recommendations rooted in science and data that impact the skin.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 14
- Website
- veracityhealth.co/
- Ownership
- Privately Held (backing)
Veracity (Personal Products) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Veracity (Personal Products) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Veracity (Personal Products) in its N-PORT filings yet. We sweep new filings monthly.